Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea

R Hehlmann; U Berger; M Pfirrmann; A Hochhaus; G Metzgeroth; O Maywald; J Hasford; A Reiter; DK Hossfeld; HJ Kolb; H Loffler; H Pralle; W Queisser; M Griesshammer; C Nerl; R Kuse; A Tobler; H Eimermacher; A Tichelli; C Aul; Martin Wilhelm; JT Fischer; M Perker; C Scheid; M Schenk; J Weiss; CR Meier; S Kremers; L Labedzki; T Schmeiser; HP Lohrmann; H Heimpel

doi:10.1038/sj.leu.2403006

Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea

R Hehlmann, U Berger, M Pfirrmann, A Hochhaus, G Metzgeroth, O Maywald, J Hasford, A Reiter, DK Hossfeld, HJ Kolb, H Loffler, H Pralle, W Queisser, M Griesshammer, C Nerl, R Kuse, A Tobler, H Eimermacher, A Tichelli, C AulMartin Wilhelm (Co-author), JT Fischer, M Perker, C Scheid, M Schenk, J Weiss, CR Meier, S Kremers, L Labedzki, T Schmeiser, HP Lohrmann, H Heimpel

Research output: Contribution to journal › Original Article (Journal) › peer-review

57 Citations (Web of Science)

Original language	English
Pages (from-to)	1529-1537
Journal	LEUKEMIA
Volume	17
Issue number	8
DOIs	https://doi.org/10.1038/sj.leu.2403006
Publication status	Published - 2003

Keywords

CHRONIC MYELOGENOUS LEUKEMIA
BONE-MARROW-TRANSPLANTATION
POLYMERASE CHAIN-REACTION
CYTOGENETIC RESPONSE
CHRONIC-PHASE
CONVENTIONAL CHEMOTHERAPY
BUSULFAN
THERAPY
TRIALS
CYTARABINE

Access to Document

10.1038/sj.leu.2403006

Cite this

Hehlmann, R., Berger, U., Pfirrmann, M., Hochhaus, A., Metzgeroth, G., Maywald, O., Hasford, J., Reiter, A., Hossfeld, DK., Kolb, HJ., Loffler, H., Pralle, H., Queisser, W., Griesshammer, M., Nerl, C., Kuse, R., Tobler, A., Eimermacher, H., Tichelli, A., ... Heimpel, H. (2003). Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. LEUKEMIA , 17(8), 1529-1537. https://doi.org/10.1038/sj.leu.2403006

Hehlmann, R ; Berger, U ; Pfirrmann, M et al. / Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. In: LEUKEMIA 2003 ; Vol. 17, No. 8. pp. 1529-1537.

@article{d0f7f8900d6e4be888360acbf1c9f24f,

title = "Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea",

keywords = "CHRONIC MYELOGENOUS LEUKEMIA, BONE-MARROW-TRANSPLANTATION, POLYMERASE CHAIN-REACTION, CYTOGENETIC RESPONSE, CHRONIC-PHASE, CONVENTIONAL CHEMOTHERAPY, BUSULFAN, THERAPY, TRIALS, CYTARABINE",

author = "R Hehlmann and U Berger and M Pfirrmann and A Hochhaus and G Metzgeroth and O Maywald and J Hasford and A Reiter and DK Hossfeld and HJ Kolb and H Loffler and H Pralle and W Queisser and M Griesshammer and C Nerl and R Kuse and A Tobler and H Eimermacher and A Tichelli and C Aul and Martin Wilhelm and JT Fischer and M Perker and C Scheid and M Schenk and J Weiss and CR Meier and S Kremers and L Labedzki and T Schmeiser and HP Lohrmann and H Heimpel",

year = "2003",

doi = "10.1038/sj.leu.2403006",

language = "English",

volume = "17",

pages = "1529--1537",

journal = "LEUKEMIA ",

issn = "0887-6924",

number = "8",

}

Hehlmann, R, Berger, U, Pfirrmann, M, Hochhaus, A, Metzgeroth, G, Maywald, O, Hasford, J, Reiter, A, Hossfeld, DK, Kolb, HJ, Loffler, H, Pralle, H, Queisser, W, Griesshammer, M, Nerl, C, Kuse, R, Tobler, A, Eimermacher, H, Tichelli, A, Aul, C, Wilhelm, M, Fischer, JT, Perker, M, Scheid, C, Schenk, M, Weiss, J, Meier, CR, Kremers, S, Labedzki, L, Schmeiser, T, Lohrmann, HP & Heimpel, H 2003, 'Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea', LEUKEMIA , vol. 17, no. 8, pp. 1529-1537. https://doi.org/10.1038/sj.leu.2403006

Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. / Hehlmann, R; Berger, U; Pfirrmann, M et al.
In: LEUKEMIA , Vol. 17, No. 8, 2003, p. 1529-1537.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea

AU - Hehlmann, R

AU - Berger, U

AU - Pfirrmann, M

AU - Hochhaus, A

AU - Metzgeroth, G

AU - Maywald, O

AU - Hasford, J

AU - Reiter, A

AU - Hossfeld, DK

AU - Kolb, HJ

AU - Loffler, H

AU - Pralle, H

AU - Queisser, W

AU - Griesshammer, M

AU - Nerl, C

AU - Kuse, R

AU - Tobler, A

AU - Eimermacher, H

AU - Tichelli, A

AU - Aul, C

AU - Wilhelm, Martin

AU - Fischer, JT

AU - Perker, M

AU - Scheid, C

AU - Schenk, M

AU - Weiss, J

AU - Meier, CR

AU - Kremers, S

AU - Labedzki, L

AU - Schmeiser, T

AU - Lohrmann, HP

AU - Heimpel, H

PY - 2003

Y1 - 2003

KW - CHRONIC MYELOGENOUS LEUKEMIA

KW - BONE-MARROW-TRANSPLANTATION

KW - POLYMERASE CHAIN-REACTION

KW - CYTOGENETIC RESPONSE

KW - CHRONIC-PHASE

KW - CONVENTIONAL CHEMOTHERAPY

KW - BUSULFAN

KW - THERAPY

KW - TRIALS

KW - CYTARABINE

U2 - 10.1038/sj.leu.2403006

DO - 10.1038/sj.leu.2403006

M3 - Original Article (Journal)

C2 - 12886239

SN - 0887-6924

VL - 17

SP - 1529

EP - 1537

JO - LEUKEMIA

JF - LEUKEMIA

IS - 8

ER -

Hehlmann R, Berger U, Pfirrmann M, Hochhaus A, Metzgeroth G, Maywald O et al. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. LEUKEMIA . 2003;17(8):1529-1537. doi: 10.1038/sj.leu.2403006